Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

aTYR PHARMA (ATYR) Income from Non-Controlling Interests (2020 - 2025)

aTYR PHARMA's Income from Non-Controlling Interests history spans 6 years, with the latest figure at -$1000.0 for Q4 2025.

  • For Q4 2025, Income from Non-Controlling Interests changed 0.0% year-over-year to -$1000.0; the TTM value through Dec 2025 reached -$5000.0, down 600.0%, while the annual FY2025 figure was -$5000.0, 600.0% down from the prior year.
  • Income from Non-Controlling Interests reached -$1000.0 in Q4 2025 per ATYR's latest filing, up from -$2000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $4000.0 in Q1 2024 to a low of -$4000.0 in Q1 2021.
  • Average Income from Non-Controlling Interests over 5 years is -$1368.4, with a median of -$1000.0 recorded in 2021.
  • Peak YoY movement for Income from Non-Controlling Interests: crashed 300.0% in 2021, then skyrocketed 500.0% in 2024.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$2000.0 in 2021, then changed by 0.0% to -$2000.0 in 2022, then soared by 50.0% to -$1000.0 in 2023, then changed by 0.0% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Income from Non-Controlling Interests are -$1000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$1000.0 (Q2 2025).